GLP-1 receptor agonists, traditionally used for metabolic regulation and weight management, are emerging as potential neuroprotective agents. Research indicates that these hormones influence brain regions critical for memory, decision-making, and movement, such as the hippocampus and basal ganglia. By supporting synaptic plasticity, reducing oxidative stress, curbing neuroinflammation in microglia, and enhancing mitochondrial function, GLP-1 signaling may help mitigate the progression of neurodegenerative conditions like Alzheimer's and Parkinson's disease. While current evidence relies heavily on animal models and preliminary human data, the gut-brain axis suggests a profound connection between metabolic health and neuronal survival. Maintaining metabolic stability and healthy sleep cycles remains a foundational strategy for preserving long-term brain function, as these systems are deeply intertwined with the protective mechanisms now being attributed to GLP-1 pathways.
Sign in to continue reading, translating and more.
Open full episode in Podwise
